Tizanidine
PolandMedications containing this active substance
-
Sirdalud
Form: tablets
Active substance Dosage Tizanidine 4 mg ATC: M03BX02
Manufacturer: Hexal AG
-
Sirdalud
Form: tablets
Active substance Dosage Tizanidine 4 mg ATC: M03BX02
Manufacturer: HEXAL AG
-
Sirdalud
Form: tablets
Active substance Dosage Tizanidine 4 mg ATC: M03BX02
Manufacturer: Sandoz s.r.o.
-
Sirdalud
Form: tablets
Active substance Dosage Tizanidine 4 mg ATC: M03BX02
Manufacturer: Sandoz s.r.o.
-
Sirdalud
Form: tablets
Active substance Dosage Tizanidine 4 mg ATC: M03BX02
Manufacturer: Sandoz s.r.o.
-
Sirdalud
Form: tablets
Active substance Dosage Tizanidine 4 mg ATC: M03BX02
Manufacturer: Sandoz d.d.
-
Sirdalud
Form: tablets
Active substance Dosage Tizanidine 4 mg ATC: M03BX02
Manufacturer: Sandoz d.d.
-
Sirdalud
Form: tablets
Active substance Dosage Tizanidine 4 mg ATC: M03BX02
Manufacturer: Hexal AG
-
Sirdalud
Form: tablets
Active substance Dosage Tizanidine 4 mg ATC: M03BX02
Manufacturer: Sandoz d.d.
-
Sirdalud
Form: tablets
Active substance Dosage Tizanidine 4 mg ATC: M03BX02
Manufacturer: Bexal Farmaceutica, S.A.
-
Sirdalud
Form: tablets
Active substance Dosage Tizanidine 4 mg ATC: M03BX02
Manufacturer: Bexal Farmaceutica, S.A.
-
Sirdalud
Form: tablets
Active substance Dosage Tizanidine 4 mg ATC: M03BX02
Manufacturer: Sandoz Hungária Ltd.
-
Sirdalud
Form: tablets
Active substance Dosage Tizanidine 4 mg ATC: M03BX02
Manufacturer: Bexal Farmaceutica, S.A.
-
Sirdalud mr
Form: capsules, hard modified release
Active substance Dosage Tizanidine 6 mg ATC: M03BX02
Manufacturer: Lek Pharmaceuticals d.d. Novartis Farmacéutica, S.A. Novartis Pharma GmbH Novartis Poland Sp. z o.o.